Abstract
Studies to characterize Hodgkin and Reed-Sternberg cells in histological sections have yielded many conflicting data over the years. Even with progress in immunohistological technology, the histogenetic derivation of these cells remains unclear. Functional and genetic investigations are hampered by the scarcity of tumor cells in Hodgkin’s disease biopsy samples and the admixture of a variety of nonmalignant cells.
Keywords
- Migration Inhibitory Factor
- Diehl Versus
- Nodular Sclerosing Subtype
- Transform Growth Factor Beta Activity
- Cell Line Cell Line
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Bieber MM, King DP, Strober S, Kaplan HS (1979) Characterization of an E-rosette inhibitor in the serum of patients with Hodgkin’s disease as a glycolipid. Clin Res 27: 81A
Breitmeyer JB (1987) Lymphocyte activation; how T cells communicate. Nature 329: 760–761
Burrichter H, Heit W, Schaadt M, Kirchner HH, Diehl V (1983) Production of colony stimulating factors by Hodgkin cell lines. Int J Cancer 31: 269–274
Cheng G, Minden M, Toyonaga B, Mak T, McCullogh A (1986) T-cell receptor and immunoglobulin gene rearrangements in acute myelobastic leukemia. J Exp Med 163: 414–424
Diehl V, Kirchner HH, Burrichter H, Stein H, Fonatsch C, Gerdes J, Schaadt M, Heit W, Uchanska-Ziegler B, Ziegler A, Heintz H, Sueno K (1982) Characteristics of Hodgkin’s disease-derived cell lines. Cancer Treat Rep 66: 615–632
Drexler HG, Gaedicke G, Lok MS, Diehl V, Minowada J (1986) Hodgkin’s disease derived cell lines HDLM-2 and L 428. Comparison of morphology, immunological and isoenzyme profiles. Leuk Res 10: 487–500
Falk M, Tesch H, Stein H, Diehl V, Jones D, Fonatsch C, Bornkamm G (1987) Phenotype versus immunoglobulin and T-cell receptor genotype of Hodgkin derived cell lines: activation of immature lymphoid cells in Hodgkin’s disease. Int J Cancer 40: 262–269
Fischer RI, Bostick-Bruton F, Sander DN, Scala G, Diehl V (1983) Neoplastic cells obtained from Hodgkin’s disease are potent stimulators of human primary mixed lymphocyte cultures. J Immunol 130: 2666–2670
Fonatsch C, Diehl V, Schaadt M, Burrichter H, Kirchner HH (1986) Cytogenetic investigations in Hodgkin’s disease: I. Involvement of specific chromosomes in marker formation. Cancer Genet Cytogenet 20: 39–52
Giovanella BC, Nilsson K, Zeich L, Yim O, Klein G, Stehlin JS (1979) Growth of diploid, Epstein-Barr-virus-carrying human lymphoblastoid cell lines heterotransplanted into nude mice under immunologically privileged conditions. Int J Cancer 24: 103–113
Jones DB, Scott CS, Wright DH, Stein H, Beverly PCL, Payne SV, Crawford DH (1985) Phenotype analysis of an established cell line derived from a patient with Hodgkin’s disease (HD). Hematol Oncol 3: 133–145
Kamesaki H, Fukuhara S, Tatsumi E, Uchino H, Yamabe H, Miwa H, Shiragawa S, Hatanaka M, Honjo T (1986) Cytochemical, immunologic, chromosomal and molecular genetic analysis of a novel cell line derived from Hodgkin’s disease. Blood 68: 285–292
Kortmann C, Burrichter H, Jahn G, Diehl V, Peter HH (1984) Interleukin-1 activity constitutively generated by Hodgkin derived cell lines. I. Measurement in a human lymphocyte costimulator assay. Immunobiology 166: 318–333
Lozzio BB, Lozzio CB, Machado E (1976) Human myelogenous (Ph1 +) leukemia cell-line; transplantation into athymic mice. JNCI 56: 627–628
Meuer S, Hussey R, Fabbi M, Fox D, Acuto O, Fitzgerald K, Hodgdon J, Protentis J, Schlossman S, Reinherz E (1984) An alternative pathway of T-cell activation: a functional role for the 50 kd T 11 sheep erythrocyte receptor protein. Cell 36: 897–906
Newcom S, Kadin ME, Ansari AA (1988) Production of transforming growth factor beta activity by Ki-1 positive lymphoma cells and analysis of its role in the regulation of Ki-1 positive lymphoma growth. Am J Pathol 131 (3): 569–577
Olsson L, Behnke O, Pleibel N, D’Amore F, Werdelin O, Fry KE, Kaplan HS (1984) Establishment and characterization of a clonal gaint cell line from a patient with Hodgkin’s disease. JNCI 73: 809–830
Pfreundschuh M, Mommerz E, Meissner M, Feller A, Hassa R, Krueger HR, Diehl V (1988) Hodgkin and Reed-Sternberg cells associated monoclonal antibodies HRS-1 and HRS-2 react with activated cells of lymphoid and monocytoid origin. Anticancer Res 8: 217–224
Poppema S, De Jong B, Atmosoerodjo J, Idenburg V, Visser L, De Ley L (1985) Morphologic, immunologic, enzyme histochemical and chromosomal analysis of a cell line derived from Hodgkin’s disease. Evidence for a B-cell origin of Sternberg-Reed cells. Cancer 55: 683–690
Schaadt M, Kirchner H, Fonatsch C, Diehl V (1979) Intracranial heterotransplantation of human hematopoetic cells in “nude”-mice. Int J Cancer 23: 751–561
Schaadt M, Diehl V, Stein H, Fonatsch C, Kirchner H (1980) Two neoplastic cell lines with unique features derived from Hodgkin’s disease. Int J Cancer 26: 723–731
Schell-Frederick E, Radtke H, Sommer H, Helbing I, Burrichter H, Schaadt M, Diehl V (1988) Inhibition of human neutrophil migration by supernatants from Hodgkin’s disease derived cell lines. Eur Clin Invest 18: 290–296
Schwab U, Stein H, Gerdes J, Lemke H, Kirchner HH, Schaadt M, Diehl V (1982) Production of a monoclonal antibody specific for Hodgkin-and Sternberg-Reed-cells of Hodgkin’s lymphoma and a subset of normal lymphoid cells. Nature 299: 65–67
Stein H, Gerdes J, Schwab U, Lemke H, Mason DY, Ziegler A, Schienle W, Diehl V (1982) Identification of Hodgkin and Sternberg-Reed cells as a unique cell type derived from a newly detected small-cell population. Int J Cancer 30: 445–459
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1989 Springer-Verlag Berlin · Heidelberg
About this paper
Cite this paper
Schaadt, M. et al. (1989). Biology of Hodgkin Cell Lines. In: Diehl, V., Pfreundschuh, M., Loeffler, M. (eds) New Aspects in the Diagnosis and Treatment of Hodgkin’s Disease. Recent Results in Cancer Research, vol 117. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-83781-4_5
Download citation
DOI: https://doi.org/10.1007/978-3-642-83781-4_5
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-83783-8
Online ISBN: 978-3-642-83781-4
eBook Packages: Springer Book Archive